Latest Hazardous drugs Stories
Portfolio Showcased at ONS--Nationally Renowned Congress for Oncology Education BETHLEHEM, Pa., April 23, 2013 /PRNewswire/ -- B. Braun Medical Inc. (B.Braun) has made a longstanding commitment to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety with products, services and education focused on sharing best clinical practices. B.Braun will exhibit (Booth 1125) its latest protective engineering devices at the Oncology Nursing Society...
National Safe Handling Awareness Month Webinar Calls Attention to Hazardous Drug Handling, Safety Precautions and Standards FRANKLIN LAKES, N.J., April 17, 2013 /PRNewswire/ -- While the Occupational Safety and Health Administration (OSHA) has classified chemotherapy drugs - which are designed to be toxic and highly absorbable in order to fight cancers - as hazardous since the 1980s, there are insufficient federal or state regulations to limit healthcare workers' exposure to these...
New Version of the Microbiologically and Mechanically Closed Needlefree Automated System to Make Its European Debut at the European Association of Hospital Pharmacists (EAHP) 18th Congress in Paris March 13-15 2013 SAN CLEMENTE, Calif., March 12, 2013 /PRNewswire/ -- ICU Medical, Inc. (NASDAQ: ICUI) today announced the European launch of a new version of Diana Hazardous Drug Compounding System at the European Association of Hospital Pharmacists (EAHP) 18th Congress in Paris, France...
NASHVILLE, Tenn., March 7, 2013 /PRNewswire/ -- APOTECAchemo(TM) (Apoteca) presents a consolidated approach to managing patient safety, staff safety, overall efficiency, and cost control in the area of hazardous IV compounding. With Apoteca, you can achieve the safety and accuracy benefits of automation with a compelling value proposition. You can see APOTECAchemo in live operation on a daily basis at leading cancer treatment facilities in the United States and five other...
FRANKLIN LAKES, N.J., Jan. 15, 2013 /PRNewswire/ -- BD Medical, a segment of BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced that the U.S. Food and Drug Administration (FDA) has cleared the BD PhaSeal(TM) Closed System Transfer Device (CSTD) under the newly created ONB code. The BD PhaSeal System is the first and only cleared CSTD under the new code, which was created for devices that have specific indications for use...
SAN CLEMENTE, Calif., Nov. 29, 2012 /PRNewswire/ -- ICU Medical, Inc. (NASDAQ: ICUI) today announced the U.S. launch of the Diana Hazardous Drug Compounding System at the American Society of Health System Pharmacists (ASHP) Midyear Meeting and Exposition in Las Vegas December 2-6, 2012. The Diana system is the world's first user-controlled automated sterile compounding system for the accurate, safe, and efficient preparation of hazardous drugs, and has been in clinical use in Europe...
SAN CLEMENTE, Calif., Oct. 22, 2012 /PRNewswire/ -- A recent high-profile incident involving drug contamination and patient deaths associated with a compounding pharmacy underscores the safety challenges associated with current drug compounding processes throughout the country. Fortunately, there is a system available today that may help ensure the sterility of drugs during the drug compounding process. The Diana(TM) Hazardous Drug Compounding System, manufactured by ICU Medical,...
SAN CLEMENTE, Calif., Sept. 6, 2012 /PRNewswire/ -- ICU Medical, Inc. (Nasdaq:ICUI) today announced they will be hosting a presentation by Seth Eisenberg, RN, OCN(®), titled "Nurse Safety with Hazardous Drugs: Where Do You Stand?" to educate nurses about the dangers of exposure to hazardous drugs and examine methods for exposure prevention. This presentation to attendees of the International Conference on Cancer Nursing (ICCN) will be held at the Hilton Prague Hotel, Prague, CZ,...
SAN CLEMENTE, Calif. and ST. LOUIS, June 7, 2012 /PRNewswire/ -- ICU Medical, Inc. (NASDAQ: ICUI) and Mobius Therapeutics, LLC today jointly announced that ICU Medical's ChemoClave(TM) system for the safe handling of hazardous drugs will be packaged with Mobius Therapeutics' Mitosol® kit, an FDA-cleared drug used in ophthalmic surgery containing the active ingredient Mitomycin-C, which is cytotoxic and listed on NIOSH Hazardous Drug List. By incorporating ChemoClave components...
NEW ORLEANS, May 3, 2012 /PRNewswire-FirstCall/ -- ICU Medical, Inc. (NASDAQ: ICUI) today announced that two studies presented this week at the 37th Annual Congress of the Oncology Nursing Society (ONS) in New Orleans show that the company's ChemoClave(TM) needlefree closed system transfer device (CSTD) protects nurses from accidental exposure to hazardous chemotherapy drugs while increasing nurse satisfaction and perceptions of safety. The ChemoClave system is the...
